We have invested in unique and differentiating pharmaceutical technologies that position us well among the strong players of the industry.
Our most known proprietary transdermal systems are our nitroglycerine patch indicated for the prevention of angina and our fentanyl patch for acute, chronic pain. Both products, manufactured in our plant, are exported and are marketed in international markets under different brand names.
With an extensive expertise in the science of skin, our R&D has also developed an epidermal patch for acne prone skin that was marketed by L’OREAL in more than 40 countries.
For more information, please contact: researchdevelopment@lavipharm.com